Ligand · BXJ
BXJ · N-{3-[(2R)-6-{[3-amino-4-(morpholine-4-carbonyl) phenyl]amino}-5-oxo-2,5-dihydropyrazin-2-yl]-2-methylphenyl}-4-(piperidin-1-yl)benzamide
BXJ, N-{3-[(2R)-6-{[3-amino-4-(morpholine-4-carbonyl) phenyl]amino}-5-oxo-2,5-dihydropyrazin-2-yl]-2-methylphenyl}-4-(piperidin-1-yl)benzamide (C34 H37 N7 O4, 607.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…
- Component
- BXJ
- Formula
- C34 H37 N7 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BXJ in 2 structures; the first of them:
- 6AUA · Crystal structure of BRUTON'S tyrosine kinase in complex with inhibitor CGI2625 · BXJ A704 · binds LEU408, GLY409, THR410, GLY411, GLN412, PHE413, VAL416, ALA428 and 15 more
- 6AUA · Crystal structure of BRUTON'S tyrosine kinase in complex with inhibitor CGI2625 · BXJ A704 · binds LEU408, GLY409, THR410, GLY411, GLN412, PHE413, VAL416, ALA428 and 15 more
Residues it binds most
GLY 2, LEU 2, ALA 2, ASN 2, ASP 2, TYR 2, VAL 2, GLN 2, GLU 2, LYS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.